AstraZeneca Pharma India informs about appointment of senior management personnel

15 Sep 2023 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved the appointment of Praveen Akkinepally as the Business Unit Head – Oncology with effect from November 1, 2023. Praveen will be part of the Senior Management team of the Company. In this regard, the company has enclosed the details as required under the SEBI Circular SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 as Annexure – A.

The above information is a part of company’s filings submitted to BSE.


Astrazeneca Pharma I Share Price

6364.75 75.85 (1.21%)
22-Nov-2024 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.30
Dr. Reddys Lab 1203.80
Cipla 1486.80
Lupin 2058.15
Zydus Lifesciences 946.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.